The GSN gene encodes gelsolin, a highly conserved actin-binding protein that plays critical roles in regulating the dynamics of the actin cytoskeleton. Gelsolin is essential for cell motility, membrane remodeling, and cytoplasmic streaming. Importantly, gelsolin has emerged as a significant player in neurodegenerative diseases, particularly amyotrophic lateral sclerosis (ALS) and Alzheimer's disease (AD), where dysregulation of actin dynamics contributes to neuronal dysfunction and death.
| Attribute |
Value |
| Symbol |
GSN |
| Full Name |
Gelsolin |
| Chromosomal Location |
9q34.11 |
| NCBI Gene ID |
2694 |
| OMIM ID |
137350 |
| Ensembl ID |
ENSG00000148180 |
| UniProt ID |
P06396 |
| Protein Size |
755 amino acids |
| Molecular Weight |
~82 kDa |
¶ Protein Structure and Function
Gelsolin is a calcium-activated actin-binding protein that belongs to the villin/gelsolin superfamily. It contains six homologous repeats (S1-S6), each ~150 amino acids long, with distinct functions:
- Calcium Binding: Gelsolin requires calcium for activation, which induces conformational changes enabling actin binding
- Severing: Gelsolin severs actin filaments by inserting between actin subunits
- Capping: After severing, gelsolin caps the barbed end, preventing filament elongation
- Nucleation: Gelsolin can nucleate new actin filament formation
The protein exists in two forms:
- Cytoplasmic gelsolin: Found in most cell types, involved in cell motility
- Plasma gelsolin: Secreted form that circulates in blood, involved in actin clearance
In neurons, gelsolin plays important roles in:
- Synaptic Plasticity: Regulates actin dynamics at synaptic spines, affecting synaptic strength and remodeling
- Axonal Transport: Facilitates vesicular transport through dynamic actin networks
- Dendritic Branching: Supports proper dendritic arborization during development
- Presynaptic Function: Regulates neurotransmitter release through actin remodeling
Gelsolin is expressed in most cell types throughout the body:
- Brain: High expression in neurons and glial cells, particularly in the cortex, hippocampus, and cerebellum
- Other tissues: Highest in fibroblasts, macrophages, platelets, and smooth muscle cells
Gelsolin mutations were first linked to familial ALS in 2007. Key findings:
- D255N and G255R mutations: Cause autosomal dominant ALS
- Mechanism: Mutations impair gelsolin's ability to regulate actin dynamics in motor neurons
- Cytoplasmic aggregates: Mutant gelsolin forms inclusions in affected neurons
- Therapeutic implications: Gene therapy approaches to restore gelsolin function are being explored
Gelsolin is implicated in AD pathogenesis through multiple mechanisms:
- Amyloid-beta interaction: Gelsolin can bind Aβ peptides, potentially modulating plaque formation
- Actin cytoskeleton disruption: Aβ toxicity involves actin cytoskeleton remodeling that gelsolin may modulate
- Tau pathology: Gelsolin phosphorylation state affects tau-related neuronal dysfunction
Gelsolin has been identified as a genetic modifier of SMA severity:
- Expression levels: Higher gelsolin expression correlates with increased disease severity
- Mechanism: Alters motor neuron vulnerability through actin-dependent pathways
| Approach |
Strategy |
Status |
| Gene therapy |
Deliver wild-type gelsolin to neurons |
Preclinical |
| Small molecules |
Actin cytoskeleton modulators |
Research |
| Antisense oligonucleotides |
Reduce toxic mutant expression |
Research |
- Gelsolin-deficient mice show increased susceptibility to neuronal injury
- Plasma gelsolin levels are reduced in AD patients, suggesting potential biomarker utility
- Gelsolin fragments are found in AD brains, indicating proteolytic processing